Post-ejection thickening as a marker of viable myocardium. An echocardiographic study in patients with chronic coronary artery disease

Basic Res Cardiol. 1998 Aug;93(4):313-24. doi: 10.1007/s003950050100.

Abstract

The study aim was to assess whether post-ejection thickening (PT) is an useful marker of viable myocardium in patients with chronic coronary artery disease. Twenty-three patients with critical coronary stenoses were submitted to dobutamine and dipyridamole stress-echocardiographies and dipyridamole-early-redistribution 201Tl SPECT within 15 days from coronary arteriography. They were selected for the presence of PT in segments that could be optimally studied by M-mode echocardiography and were hypo-akinetic in basal conditions. PT (occurring between end-ejection and mitral valve opening) was found in 58% of dysfunctional, critically perfused regions. Ninety-eight percent of the regions with PT and 6% of those without PT improved during low-dose dobutamine stress-echocardiography. Segments with PT had, respectively, higher and lower SPECT early-redistribution thallium activity than dysfunctional segments without PT and normokinetic regions. Therefore, regions with PT were viable and had a moderate decrease in coronary perfusion. Akinetic segments without PT did not show any inotropic reserve. After revascularization almost all the segments with PT improved. In conclusion, PT is a pattern of myocardial contraction easily detected by M-mode echocardiography in the clinical setting. If the results of this study are further confirmed, PT may become a sign for the recognition of myocardial viability.

MeSH terms

  • Adult
  • Angioplasty
  • Biomarkers
  • Cardiotonic Agents
  • Chronic Disease
  • Coronary Artery Bypass
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / physiopathology*
  • Dipyridamole
  • Dobutamine
  • Exercise Test
  • Female
  • Heart / physiopathology*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Stroke Volume / physiology*
  • Tomography, Emission-Computed, Single-Photon
  • Ultrasonography
  • Vasodilator Agents

Substances

  • Biomarkers
  • Cardiotonic Agents
  • Vasodilator Agents
  • Dobutamine
  • Dipyridamole